The Advantages of L-Das Over Remission in the Lupus Cohort

The numbers look pretty promising there. I think it just sort of takes on the fact that not just remission, even low disease activity is probably a good target for these difficult patients sometimes. Just achieving that also improves our outcome significantly in terms of flare, damage, mortality,. So yeah. Am I right in that the take home was that there are advantages to L, L-DAS over remission in the lupus cohort they look like?